LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LEMAITRE VASCULAR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)
Close on Oct 19, 2026
- Market cap
- $2.02B
- P/E (TTM)
- 28.9
- Dividend yield
- 0.97%
Share price
−$4.29 (−4.95%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
LEMAITRE VASCULAR INC grew revenue 11.8% to $262.43M over the twelve months to Jun 30, 2026. Operating income rose 41.2% to $77.32M, moving the operating margin from 23.3% to 29.5%. Free cash flow was $73.83M, up 41.1% from a year earlier.
Revenue
$262.43M
+11.8% vs. a year earlier
Operating income
$77.32M
+41.2% vs. a year earlier
Free cash flow
$73.83M
+41.1% vs. a year earlier
EPS, diluted
$2.85
+38.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.02B
- P/E ratio
- 28.9
- Price to sales
- 7.69
- Price to book
- 4.80
- Dividend yield
- 0.97%
- Free cash flow yield
- 3.66%
Fundamentals
- Revenue
- $262.43M
- Net income
- $65.67M
- EPS, diluted
- $2.85
- Free cash flow
- $73.83M
- Book value per share
- $17.14
- Diluted shares
- 25M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$262.43M+11.8% YoY
Gross profit
$191.31M+18.0% YoY
Operating income
$77.32M+41.2% YoY
Net income
$65.67M+39.4% YoY
EPS, diluted
$2.85+38.3% YoY
Free cash flow
$73.83M+41.1% YoY
Reported periodTrailing twelve months